三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABU 三倍做多标普生物-Direxion

盘后交易 11-10 18:55:14 EST

236.32

-8.79

-3.59%

盘后237.90

+1.58+0.67%

18:24 EST

最高249.60	最低227.17	成交量29.11万
今开237.59	昨收245.11	日振幅9.15%
总市值5.85亿	流通市值5.85亿	总股本247.45万
成交额6,900万	换手率11.76%	流通股本247.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":236.32,"timestamp":1794344400000,"preClose":245.11,"halted":0,"volume":291103,"hourTrading":{"tag":"盘后","latestPrice":237.9,"preClose":236.32,"latestTime":"18:24 EST","volume":956,"amount":225780.31728,"timestamp":1794353087992,"change":1.58,"changeRate":0.006686,"amplitude":0.011848},"delay":0,"changeRate":-0.03586144996124197,"floatShares":2474486,"shares":2474486,"eps":0,"marketStatus":"盘后交易","change":-8.79,"latestTime":"11-10 18:55:14 EST","open":237.59,"high":249.6,"low":227.1705,"amount":68999590.9943,"amplitude":0.091508,"askPrice":237.4,"askSize":3,"bidPrice":236.32,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794358800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":245.11,"sharesOutstanding":3024486,"nav":244.545,"aum":617349396.56,"dividendRate":0.003838,"bidAskSpread":0.003595,"preHourTrading":{"tag":"盘前","latestPrice":238.7616,"preClose":245.11,"latestTime":"09:29 EST","volume":3664,"amount":883367.9396800001,"timestamp":1794320991070,"change":-6.3484,"changeRate":-0.0259,"amplitude":0.040512},"postHourTrading":{"tag":"盘后","latestPrice":237.9,"preClose":236.32,"latestTime":"18:24 EST","volume":956,"amount":225780.31728,"timestamp":1794353087992,"change":1.58,"changeRate":0.006686,"amplitude":0.011848},"volumeRatio":0.744818,"impliedVol":1.0798,"impliedVolPercentile":0.9323},"requestUrl":"/m/hq/s/LABU","defaultTab":"news","newsList":[{"id":"2682155153","title":"雅培(ABT.US)：旗下Ultisynq导线获得美国食品药品监督管理局（FDA）批准及欧盟CE标志认证。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682155153","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682155153?lang=zh_cn&edition=full","pubTime":"2026-11-10 22:03","pubTimestamp":1794319438,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1691799644.USD","LU1670627923.USD","BK4568","ABT","SGXZ23171101.USD","BK4581","LU2089984988.USD","SG9999002224.SGD","LU0058720904.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0234572021.USD","IE00B2B36J28.USD","LU0432979614.USD","LU1983299246.USD","IHI","LU2211815571.USD","LU0882574055.USD","BK4082","LU1989763690.USD","LU1670628061.USD","BK4592","LU2324357040.USD","IE0002141913.USD","LU2468319806.SGD","LU0868494617.USD","PJP","LU0320765489.SGD","LABU","LU0208291251.USD","LU1721429741.USD","BK4585","LU0070302665.USD","BK4533","LU0114720955.EUR","LU2237957902.USD","LU0170899867.USD","LU0289739699.SGD","SG9999004303.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU2133065610.SGD","TMED","LU2112291526.USD","SG9999002232.USD","LU0266013472.USD","LU0211331839.USD","LU1989763427.SGD","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682318835","title":"GOODRX股价盘前上涨6.4%，此前该公司与GEMINI达成医疗保健协议。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682318835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682318835?lang=zh_cn&edition=full","pubTime":"2026-11-10 21:09","pubTimestamp":1794316168,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VHT","BK4581","CGVV","BK4588","BK4550","XBI","XLV","LABU","NOBL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682101392","title":"BioNTech以2.05亿美元购买FDA优先审评券。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682101392","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682101392?lang=zh_cn&edition=full","pubTime":"2026-11-10 20:16","pubTimestamp":1794313016,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682922943","title":"商业医疗险示范条款正式发布：首批58款药械纳入推荐清单，32款为医保目录外自费药","url":"https://stock-news.laohu8.com/highlight/detail?id=2682922943","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682922943?lang=zh_cn&edition=full","pubTime":"2026-11-10 20:13","pubTimestamp":1794312780,"startTime":"0","endTime":"0","summary":"商业医疗保险有了行业示范条款，首批商保药品推荐清单也正式出炉。首批58款药械纳入推荐清单，近六成为医保目录外自费药此次发布的商保药品推荐清单主要针对院外特定药械责任，与短期、长期两款一般商业医疗保险示范条款配套使用。中保协表示，下一步将推动医疗险示范条款和商保药品推荐清单规范应用，并建立动态评估和调整机制，重点关注消费者反馈、药品临床应用、保险理赔及用药需求变化，适时优化相关内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-11-10/doc-iniyhfqs5825484.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-11-10/doc-iniyhfqs5825484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","XBI","XLV","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682391844","title":"精算师协会发布商业健康保险药品保障成本表 夯实药品保障精算定价基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2682391844","media":"金融一线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682391844?lang=zh_cn&edition=full","pubTime":"2026-11-10 19:23","pubTimestamp":1794309780,"startTime":"0","endTime":"0","summary":"商业健康保险药品保障成本表是行业首次编制并发布，有利于夯实创新药品保障定价基础，助力保险业有效管控风险，提供公平可及、持续稳定的健康保险服务。商业健康保险药品保障成本表编制工作搭建了沟通交流的平台，凝聚了行业合力，丰富了药品数据信息来源，提升了药品保障定价的标准化、精准化、科学化水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-11-10/doc-iniyfzhx2639539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4585","BK4588","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682396986","title":"中保协相关负责人就商业医疗保险示范条款和商业健康保险药品保障推荐清单答记者问","url":"https://stock-news.laohu8.com/highlight/detail?id=2682396986","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682396986?lang=zh_cn&edition=full","pubTime":"2026-11-10 18:25","pubTimestamp":1794306300,"startTime":"0","endTime":"0","summary":"2025年6月，中国保险行业协会健康险专委会牵头，启动医疗险示范条款和商保药品推荐清单制定工作。此次发布的医疗险示范条款和商保药品推荐清单均为示范性参考文本，不具有强制性。商保药品推荐清单是对现有商业医疗保险药品保障责任的进一步规范和完善。目前，市场上主流的商业医疗保险产品已将住院期间、在医院内发生的合理且必要的医疗费用，纳入保障范围，不受此清单限制。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/2026-11-10/doc-iniyfzhw2682863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","XLV","XBI","LABU","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682367354","title":"FDA警示Wegovy、Zepbound等热门减肥药存在失明风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2682367354","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682367354?lang=zh_cn&edition=full","pubTime":"2026-11-10 16:42","pubTimestamp":1794300130,"startTime":"0","endTime":"0","summary":"FDA 表示，目前市面所有 GLP1 药物均已有 NAION 相关病例报告。FDA 称，当前市场上所有已上市 GLP1 制剂，均收到过 NAION 的病例上报。已联系 Wegovy、Ozempic 的生产企业诺和诺德，以及 Mounjaro、Zepbound、Foundayo 的生产商礼来制药，希望获取两家公司的回应。动物实验显示，Wegovy 与 Ozempic 的活性成分司美格鲁肽，以及 Mounjaro 活性成分替尔泊肽，会导致啮齿动物出现甲状腺 C 细胞肿瘤；但目前尚不清楚该类药物是否会在人类身上诱发包括罕见甲状腺癌在内的同类肿瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-10/doc-iniyfuyw5964610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["NVOX","TRUH","FXH","BK4585","BK4588","NVOC","PINK","NBDS","RSPH","MEDI","THNR","XLVI","FHLC","PJP","CURE","NVOH","IYH","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682365452","title":"美国监管机构要求肥胖药物标注失明风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2682365452","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682365452?lang=zh_cn&edition=full","pubTime":"2026-11-10 14:33","pubTimestamp":1794292380,"startTime":"0","endTime":"0","summary":"美国监管机构宣布，诺和诺德与礼来必须在旗下减重药的药品标签上新增警示提示，说明这类爆款 GLP1 药物存在引发永久性视力丧失的潜在风险。诺和诺德表示，患者安全是公司 “第一要务”，将持续监测药品安全性，并和全球各地药监机构保持协作。FDA 指出该研究存在若干局限性，但认为有必要对这项潜在风险做进一步评估。监管机构还完成了一项临床试验荟萃分析：使用 GLP1 药物的受试者，NAION 发病率为每 10 万人年 6.4 例；对照组仅为每 10 万人年 3.8 例。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-11-10/doc-iniyfqsy5976138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682033233","title":"美国FDA要求司美格鲁肽、替尔泊肽等GLP-1药物新增眼病风险警告","url":"https://stock-news.laohu8.com/highlight/detail?id=2682033233","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682033233?lang=zh_cn&edition=full","pubTime":"2026-11-10 06:00","pubTimestamp":1794261621,"startTime":"0","endTime":"0","summary":"美国药品监管机构要求Ozempic、Zepbound等热门GLP-1药物在标签警告栏中注明潜在眼部风险，相关药企表示将配合评估，分析师认为市场影响有限。$美国食品$药品监督管理局周一要求所有具有GLP-1受体激动剂活性的药物，在标签\"警告与注意事项\"栏中新增关于非动脉炎性前部缺血性视神经病变潜在风险的相关信息。礼来发言人表示，FDA的药品安全通告适用于所有GLP-1药物，并非针对礼来产品的特定发现，公司正在仔细评估相关更新并将及时回应监管要求。","market":"other","thumbnail":"https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3785600","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","RSPH","THNR","BK4588","MEDI","NVOH","NVOC","JDOC","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682337593","title":"OpenAI：符合条件的客户还可通过AWS Marketplace获取面向医疗健康的ChatGPT和面向金融服务的Cha","url":"https://stock-news.laohu8.com/highlight/detail?id=2682337593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682337593?lang=zh_cn&edition=full","pubTime":"2026-11-10 03:03","pubTimestamp":1794251008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4581","XBI","BK4588","BK4550","IXJ","BK4585","XLV","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682647382","title":"礼来(LLY.US)减肥口服药Foundayo治疗睡眠呼吸暂停症效果显著 计划年底前申请FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2682647382","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682647382?lang=zh_cn&edition=full","pubTime":"2026-11-09 23:23","pubTimestamp":1794237786,"startTime":"0","endTime":"0","summary":"礼来计划在今年年底前向美国食品药品监督管理局提交申请，寻求批准Foundayo用于治疗肥胖或超重成年患者的中度至重度阻塞性睡眠呼吸暂停症。这一结果意味着，Foundayo有望成为又一款用于治疗睡眠呼吸暂停症的GLP-1类药物。2024年12月，礼来旗下减肥注射药物Zepbound成为首款获得美国FDA批准、用于治疗阻塞性睡眠呼吸暂停症的药物。Foundayo治疗组的AHI整体下降43.8%，显著优于安慰剂组的6.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682038264","title":"礼来(LLY.US)减肥口服药Foundayo治疗睡眠呼吸暂停症效果显著 计划年底前申请FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2682038264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682038264?lang=zh_cn&edition=full","pubTime":"2026-11-09 23:23","pubTimestamp":1794237786,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682381374","title":"美国FDA：要求GLP-1受体激动剂更改安全标签，因其可能增加罕见但严重的眼部疾病风险。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682381374","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682381374?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:29","pubTimestamp":1794234569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","JDOC","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682389071","title":"Nano-X旗下USARAD扩大与AZMED的合作，将获FDA批准的X射线人工智能技术整合进其远程放射学工作流程。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682389071","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682389071?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:22","pubTimestamp":1794234155,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["QTOC","KOMP","QDEC","QQQM","CHAT","DQJN","07522","SQQQ","PBOT","TQQQ","GPIQ","QSWN","TARK","CWC","GK","QLD","LCLG","OVQ","NEWZ","AIFD","QQQX","SOCL","LABU","ARTY","MVPS","OGIG","VUSE","MFIG","QQA","NJAN","PSQ","TECY","03034","QQQ","AQGX","TQQY","NOCT","CPNQ","03455","FWD","NAPR","WPAI","09834","NBDS","QMAR","AIQU","QID","AIBU","AGIX","NJUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681514860","title":"HALOZYME：强生公司RYBREVANT FASPRO获得FDA加速批准。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681514860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681514860?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:59","pubTimestamp":1793977152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IE00BJT1NW94.SGD","SG9999001176.USD","LU2756315318.SGD","IE000MB6IJN5.SGD","IXJ","LU2505996509.AUD","FTXH","LU1778281490.HKD","IHE","BK4568","TRUH","LU0426412945.USD","IYH","LU1032466523.USD","IE00B19Z3581.USD","SG9999001440.SGD","GDOC","VHT","LU0122379950.USD","IE00BKVL7J92.USD","BK4534","LU1066051225.USD","FHLC","LU1196500208.SGD","JDOC","SG9999002232.USD","LU0787776722.HKD","JNJ","IE0009355771.USD","LABU","LU1732799900.SGD","XLV","LU1221951046.USD","LU1059921491.USD","LU0882574055.USD","RXL","IE00B1BXHZ80.USD","LU0640476718.USD","PJP","IE0002141913.USD","LU1244550577.SGD","IE00B4R5TH58.HKD","LU0466842654.USD","MEDX","LU0432979614.USD","LU0511384066.AUD","LU0345770308.USD","LU0792757196.USD","LU2505996681.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681648618","title":"美国劳工统计局：专业和商业服务、医疗保健以及运输和仓储行业的就业人数均有所增加。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681648618","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681648618?lang=zh_cn&edition=full","pubTime":"2026-11-06 21:34","pubTimestamp":1793972098,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","XLV","BK4588","XBI","BK4581","CGVV","NOBL","BK4550","VHT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681861545","title":"福瑞医科(300049.SZ)参股公司核心产品SONOVEIN®获美国FDA De Novo许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2681861545","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681861545?lang=zh_cn&edition=full","pubTime":"2026-11-06 21:11","pubTimestamp":1793970693,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福瑞医科 发布公告，近日，公司收到参股企业法国泰拉克里昂通知及FDA De Novo许可批文，其核心产品SONOVEIN于2026年11月4日获得美国食品药品监督管理局通过De Novo途径授予的上市许可。该产品用于大隐静脉段浅表静脉反流患者的血管凝血治疗。本次获批使SONOVEIN成为美国首个且唯一获准用于静脉曲张治疗的非侵入性高强度聚焦超声平台，为美国静脉曲张患者提供了一种全新的、完全于体外完成的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","LABU","BK0028","BK4585","BK0113","300049","BK4588","BK0096","BK0114","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681639378","title":"礼来公司与Hims & Hers扩大FDA批准的礼来药物的获取渠道。","url":"https://stock-news.laohu8.com/highlight/detail?id=2681639378","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681639378?lang=zh_cn&edition=full","pubTime":"2026-11-06 19:47","pubTimestamp":1793965667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681785733","title":"福瑞医科：参股公司核心产品获美国FDA De Novo上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2681785733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681785733?lang=zh_cn&edition=full","pubTime":"2026-11-06 18:35","pubTimestamp":1793961316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LABU","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681838385","title":"强生头颈部癌症疗法获美国FDA加速批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2681838385","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681838385?lang=zh_cn&edition=full","pubTime":"2026-11-06 10:38","pubTimestamp":1793932708,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4592","LU1585245621.USD","LU1989771016.USD","LU2430703251.USD","LU2112291526.USD","BK4588","IE00BJJMRZ35.SGD","IHE","LU1057294990.SGD","LU2750360997.AUD","PJP","MEDX","IE0034235303.USD","FHLC","LU0795875169.SGD","VHT","LU1496350502.SGD","IXJ","LU0511384066.AUD","LU1674673691.USD","IE00BJT1NW94.SGD","LU0787776722.HKD","SG9999001176.SGD","LU0069063385.USD","XLV","LU2592432038.USD","BMED","SGXZ80539844.SGD","RXL","LU0210528500.USD","BK4534","IYH","TRUH","FTXH","LU1066051498.USD","JNJ","LU0820562030.AUD","LU0203345920.USD","LU0345769128.USD","LU1894683348.USD","IE000BZT7R73.USD","LU0072461881.USD","IE000SO60NU8.SGD","IE00B7SZLL34.SGD","LU0289961442.SGD","GDOC","JDOC","LABU","LU0070217475.USD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0733},{"period":"1month","weight":0.0083},{"period":"3month","weight":-0.1267},{"period":"6month","weight":0.2605},{"period":"1year","weight":1.0839},{"period":"ytd","weight":0.5378}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.014},{"period":"1year","weight":0.1218},{"period":"ytd","weight":0.1038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009536},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.135885},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.001739},{"month":5,"riseRate":0.545455,"avgChangeRate":0.013816},{"month":6,"riseRate":0.75,"avgChangeRate":0.158596},{"month":7,"riseRate":0.583333,"avgChangeRate":0.031304},{"month":8,"riseRate":0.666667,"avgChangeRate":0.021527},{"month":9,"riseRate":0.25,"avgChangeRate":-0.06835},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.048941},{"month":11,"riseRate":0.75,"avgChangeRate":0.181853},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"三倍做多标普生物-Direxion","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三倍做多标普生物-Direxion,LABU,三倍做多标普生物-Direxion股票,三倍做多标普生物-Direxion股票老虎,三倍做多标普生物-Direxion股票老虎国际,三倍做多标普生物-Direxion行情,三倍做多标普生物-Direxion股票行情,三倍做多标普生物-Direxion股价,三倍做多标普生物-Direxion股市,三倍做多标普生物-Direxion股票价格,三倍做多标普生物-Direxion股票交易,三倍做多标普生物-Direxion股票购买,三倍做多标普生物-Direxion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}